Safety and potential usefulness of liver biopsy in HIV-seropositive haemophiliacs employing a transjugular venous approach

Haemophilia

Volumn 3, Issue 3, 1997, Pages 201-204

  Gupta, R ^a   Druy, E M ^a   Kessler, C M ^a,b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chronic hepatitis; Haemophilia; HIV; Liver biopsy; Transjugular venous approach

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT ALPHA INTERFERON;

ARTICLE; BLEEDING; CHRONIC ACTIVE HEPATITIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HEMOPHILIA; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER FAILURE; NONHUMAN; PRIORITY JOURNAL; SURGICAL APPROACH; VIRUS ATTENUATION;

EID: 0030832132     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1997.00111.x     Document Type: Article

References (37)

1. Cederbaum AI, Blatt PM, Levine PH. Abnormal serum transaminase levels in patients with haemophilia A. Arch Intern Med 1982; 142: 481-4.
2. Troisi CL, Hollinger FB. A multicenter study of viral hepatitis in a United States haemophilic population. Blood 1993; 81: 412-8.
3. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus in a cohort of haemophilia patients. Blood 1990; 76: 254-6.
4. Ludlam CA, Chapman D, Cohen B, Litton PA. Antibodies to hepatitis C virus in haemophilia. Lancet 1989; 2: 560-1.
5. Noel L, Guerois C, Maisonneuve P, Verroust F, Laurian Y. Antibodies to hepatitis C virus in haemophilia. Lancet 1989; 2: 560.
6. Alter HJ, Purcell RH, Shih JW et al. Detecetion of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494-500.
7. Rumi MG, Columbo M, Gringeri A, Mannucci PM. High prevalence of antibody to hepatitis C virus in multitransfused haemophiliacs with normal transaminase levels. Ann Intern Med 1990; 112: 379-80.
8. Roggendorf M, Deinhardt F, Rassofer R, et al. Antibodies to hepatitis C virus. Lancet 1989; 2: 325-6.
9. Koretz RL, Stone O, Mousa M, Gitnick GL. Non-A, non-B post transfusion hepatitis - a decade later. Gastroenterology 1985; 88: 1251-4.
10. Realdi G, Alberto A, Rugge M. Long term follow up of acute and chronic non-a, non-B post-transfusion hepatitis: evidence of progression to cirrhosis. Gut 1982; 23: 270-5.
11. Eyster EM, Diamondstone LS, Lien J-M, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused haemophiliacs: Effect of coinfection with human immunodeficiency virus. J Acquir Immune Def Synd 1993; 6: 602-10.
12. Columbo M, Mannucci PM, Brettler DB, Girolami A, Lian ECY, Rodeghiero F. Hepatocellular carcinoma in haemophilia. Amer J Hemat 1991; 37: 243-6.
13. Makris M, Preson FE, Triger DR, et al. Hepatitis C virus and chronic liver disease in haemophilia. Lancet 1990; 335: 1117.
14. Eyster EM, Fried MW, DiBisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in Haemophiliacs. Relationship to human immunodefiiency virus infection and liver disease. Blood 1994; 84: 1020-3.
15. Jacyna MR, Thomas HC. Viral Hepatitis. Scientific Basis and Clinical Management. Zuckerman AJ, Thomas HC, eds. Churchill Livingstone, 1993; 187-92.
16. DiBisceglie AM, Martin P, Kassiandes C, et al. Recombinant interferon alpha therapy for chronic hepatitis C. N Engl J Med 1989; 321: 1506-10.
17. Davis GL, Balsrt LA, Schiff EA, et al. Treatment of chronic hepatitis C with recombinant interferon alpha. N Engl J Med 1989; 321: 1501-6.
18. Saracco G, Rosina F, Abate ML, et al. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b. Hepatology 1993; 18(6): 1300-5.
19. Sherlock S, Dooley J. Disease of Liver and Biliary System, 9th edn, p. 311.
20. Aledort LM, Levine PH, Hilgartner M, et al. A study of liver biopsies and liver disease among haemophiliacs. Blood 1985; 66: 367-72.
21. Koerper M. Alpha interferon in haemophiliacs (abstract). Liver Disease in Haemophiliacs March 1995.
22. Bonacini M. Hepatobiliary complications in patients with HIV infection. Am J Med 1992; 92: 404-11.
23. Caraceni P, Fagiuoli S, Van Thiel DH. Iron reduction therapy: simple camouflage, or a real weapon? Am J Gastroenerol 1994; 89(7): 970-2.
24. Dotter CT. Catheter biopsy: experimental technique for transvenous liver biopsy. Radiology 1964; 82: 312-4.
25. Hanafee WN, Weiner, M. Transjugular percutaneous cholangiography. Radiology 1967; 88: 35-9.
26. Rosch J, Lakin PC, Antonovic R, Dotter CT. Transjugular approach to liver biopsy and transhepatic cholangiography. N Engl J Med 1973; 289: 227-31.
27. Lebrec D, Degott C, Rueff B, Benhamou JP. Transvenous (transjugular) liver biopsy and experience based on 100 biopsies. Am J Dig Dis 1978; 23: 302-4.
28. Choy OC, Shimkin PM, Link RJ. The transjugular route as an alternative to direct percutaneous needle biopsy of the liver. Am J Gastroenterol 1978; 10: 653-6.
29. Lebrac D, Golfarb G, Degott C, Rueff B, Benhamou JP. Transvernous liver biopsy: an experience based on 1000 hepatic tissue sampling with this procedure. Gastroenterology 1982; 83: 338-40.
30. Velt PM, Choy OC, Shimkin PM, Link RJ. Transjugular liver biopsy in high risk patients with hepatic disease. Radiology 1984; 153: 91-3.
31. Gamble P, Colapinto RF, Stronell RD, Colman JC, Blendis L. Transjugular liver biopsy: a review of 461 biopsies. Radiology 1985; 157: 589-53.
32. McAfee JH, Keeffe EB, Lee RG, Rosch J. Transjugular liver biopsy. Hepatology 1992; 15: 726-32.
33. Donaldson BW, Gopinath R, Wanless IR et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology 1993; 18: 1370-4.
34. Benner K, Keeffe EB. Clinical outcome after percutaneous transhepatic obliteration of esophageal varices. Gastroenterology 1983; 85: 146-53.
35. Rosch J. Nonsurgical intrahepatic portocaval shunt: an utopian dream or an approaching reality. Hepatology 1986; 6: 1056-8.
36. Zemel G, Katzen BT, Becker GJ. Percutaneous transjugular portosystemic shunt. JAMA 1991; 266: 390-3.
37. Aguilar C, Lucia JF. Is liver biopsy really necessary in hemophiliacs with chronic hepatitis C? Haemophilia 1996; 2: 259-61.